580 related articles for article (PubMed ID: 7028394)
1. Primary aldosteronism -- screening, diagnosis and therapy.
Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
[TBL] [Abstract][Full Text] [Related]
2. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
8. Detecting and treating primary aldosteronism: primary aldosteronism.
Mantero F; Mattarello MJ; Albiger NM
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
[TBL] [Abstract][Full Text] [Related]
10. [Primary hyperaldosteronism and adrenal tumors. Clinico-surgical experience with 9 patients].
Bortolotto LA; Silva HB; Lopes HF; Jatene F; Jatene A; Pileggi F
Arq Bras Cardiol; 1994 Mar; 62(3):165-9. PubMed ID: 7980077
[TBL] [Abstract][Full Text] [Related]
11. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Biglieri EG; Kater CE; Arteaga EE
J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.
Omura M; Sasano H; Saito J; Yamaguchi K; Kakuta Y; Nishikawa T
Hypertens Res; 2006 Nov; 29(11):883-9. PubMed ID: 17345788
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of primary aldosteronism: from screening to subtype differentiation.
Mulatero P; Dluhy RG; Giacchetti G; Boscaro M; Veglio F; Stewart PM
Trends Endocrinol Metab; 2005 Apr; 16(3):114-9. PubMed ID: 15808809
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestation of aldosteronoma.
Al Fehaily M; Duh QY
Surg Clin North Am; 2004 Jun; 84(3):887-905. PubMed ID: 15145241
[TBL] [Abstract][Full Text] [Related]
16. [The clinical use of captopril in the diagnosis and treatment of primary aldosteronism].
Li J
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):2-4, 60. PubMed ID: 2204520
[TBL] [Abstract][Full Text] [Related]
17. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of primary hyperaldosteronism].
Diederich S; Bidlingmaier M; Quinkler M; Reincke M
Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
[TBL] [Abstract][Full Text] [Related]
19. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
20. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
